A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

There will be plenty of baseball played this week at Mylan Park as the American Legion Senior State Baseball Tournament will ...

Mylan NV <MYL.O> has finalized a $465 million settlement resolving U.S. Justice Department claims it overcharged the government for its EpiPen emergency allergy treatment, which became the ...

Drugmaker Mylan is launching a generic version of its own EpiPen. The lower price could quiet criticism about the high cost of the brand-name anti-allergy drug. There's also a business twist.

Mylan CEO Heather Bresch felt some rare bipartisan heat in her appearance before the House Oversight and Government Reform Committee, whose members repeatedly interrupted her scripted answers to ...

Mylan, the giant pharmaceutical company, has gotten tons of grief lately for jacking up the price of its lifesaving EpiPen. Millions of American families, including mine, carry Epis to protect ...

Drugmaker Mylan said Monday that it will offer a generic version of the life-saving allergy treatment EpiPen for half the list price of the brand-name treatment after it became the center of a ...

Mylan, the profiteering, tax-dodging drug company currently taking immense heat for jacking up the price of its Epipen by 500%, announced Thursday that it will help more patients cover their ...